FibroGen, Inc. (KYNB)
NASDAQ · Healthcare
FibroGen, Inc. Shareholder Equity 2013–2025
FibroGen, Inc. annual/quarterly shareholder equity history from 2014 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- FibroGen, Inc. shareholder equity for the quarter ending December 31, 2025 were -30.0M, a 86.69% decrease year-over-year.
- FibroGen, Inc. shareholder equity for 2025 were -30.0M, a 86.69% decrease from 2024.
- FibroGen, Inc. shareholder equity for 2024 were -225.6M, a 10.50% increase from 2023.
- FibroGen, Inc. shareholder equity for 2023 were -204.2M, a 851.96% increase from 2022.
- FibroGen, Inc. shareholder equity for 2022 were -21.4M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| FibroGen, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $-30 |
| 2024 | $-226 |
| 2023 | $-204 |
| 2022 | $-21 |
| 2021 | $209 |
| 2020 | $422 |
| 2019 | $516 |
| 2018 | $509 |
| 2017 | $528 |
| 2016 | $156 |
| 2015 | $178 |
| 2014 | $221 |
| FibroGen, Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $-30 |
| 2024-12-31 | $-226 |
| 2023-12-31 | $-204 |
| 2022-12-31 | $-21 |
| 2021-12-31 | $209 |
| 2020-12-31 | $422 |
| 2019-12-31 | $516 |
| 2018-12-31 | $509 |
| 2017-12-31 | $528 |
| 2016-12-31 | $156 |
| 2015-12-31 | $178 |
| 2014-12-31 | $221 |
FibroGen, Inc. Shareholder Equity — FAQ
FibroGen, Inc. (KYNB) shareholder equity over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see KYNB's shareholder equity history?
The chart and table above show FibroGen, Inc.'s shareholder equity by year and by quarter, including the growth rate.